CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases

MLA

David B. Page, et al. “CTLA-4 Blockade Increases Antigen-Specific CD8(+) T Cells in Prevaccinated Patients with Melanoma: Three Cases.” Cancer Immunology, Immunotherapy : CII, vol. 60, no. 8, Feb. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....99f8f53eb40d20596bf49b2a637323ca&authtype=sso&custid=ns315887.

APA

David B. Page, Achim A. Jungbluth, Sylvia Adams, Yinyan Xu, Lloyd J. Old, Humilidad F. Gallardo, Klaus J. Busam, James P. Allison, Yanyun Li, Nina Bhardwaj, Jedd D. Wolchok, Jianda Yuan, Brian A. Ginsberg, & Teresa S. Rasalan. (2011). CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases. Cancer Immunology, Immunotherapy : CII, 60(8).

Chicago

David B. Page, Achim A. Jungbluth, Sylvia Adams, Yinyan Xu, Lloyd J. Old, Humilidad F. Gallardo, Klaus J. Busam, et al. 2011. “CTLA-4 Blockade Increases Antigen-Specific CD8(+) T Cells in Prevaccinated Patients with Melanoma: Three Cases.” Cancer Immunology, Immunotherapy : CII 60 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....99f8f53eb40d20596bf49b2a637323ca&authtype=sso&custid=ns315887.